Journal article icon

Journal article

Eliminating the need for fasting with oral administration of bisphosphonates.

Abstract:

Bisphosphonates are the major treatment of choice for osteoporosis, given that they are attached preferentially by bone and significantly reduce the risk of fractures. Oral bisphosphonates are poorly absorbed (usually less than 1% for nitrogen-containing bisphosphonates) and when taken with food or beverages create complexes that cannot be absorbed. For this reason, they must be taken on an empty stomach, and a period of up to 2 hours must elapse before the consumption of any food or drink ot...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2147/tcrm.s52291

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
Journal:
Therapeutics and clinical risk management
Volume:
9
Issue:
1
Pages:
395-402
Publication date:
2013-01-01
DOI:
EISSN:
1178-203X
ISSN:
1176-6336
Language:
English
Keywords:
Pubs id:
pubs:436920
UUID:
uuid:147511e6-2fdb-49e6-8603-5db7ed0674bf
Local pid:
pubs:436920
Source identifiers:
436920
Deposit date:
2013-11-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP